Abstracts

Novel Immunization Strategies to Move on Down the Road

Presentation: Progress is being made in the development of HIV Env immunogens with the potential to activate and expand B cell precursors capable of maturing to produce broadly neutralizing antibodies (bnAbs) that could protect against HIV infection. However, such precursors are generally very rare in the human B cell repertoire and must make challenging sets…

Unveiling the Power of Uganda’s LGBTIQ Advocacy in Shaping HIV Response and Health Care Access

Presentation: Embark on an exploration of Uganda’s ongoing battle against state-sponsored homophobia and transphobia, this presentation sheds light on the vital role of LGBTIQ advocacy in shaping the country’s HIV response and healthcare access. In the face of eroding rule of law and political repression, discriminatory laws criminalizing consensual same-sex conduct have created an environment…

What’s New in HIV Vaccines: Vaccine-Induced Immune Responses

Presentation: Development of an effective HIV vaccine remains an elusive goal. Yet the search has accelerated, driven by the imperative end HIV and new directions based on promising leads in preclinical and phase 1 clinical trials. Recent breakthroughs in understanding how broadly neutralizing antibodies interact with their target epitopes on the HIV envelope spike have…

Stopping Clinical Trials Early: When and Why

Presentation: Monitoring accumulating data as studies are being performed is important. Data and Safety Monitoring Boards (DSMB) are an independent group of experts, established by the study sponsor, to review accumulating safety and efficacy data. While reviewing interim data, the DSMB may recommend stopping the study for efficacy, futility, harm, or toxicity. A recommendation to…

Modern Vaccinology: A Legacy of HIV Research

Presentation: Structure-based vaccine antigen design has been a critical determinant of respiratory syncytial virus and SARS-CoV-2 vaccine success stories. Nucleic acid vaccines and vector-based vaccine delivery have been successfully developed for Ebola and COVID-19. The ability to identify B cell lineages with the capacity for broad neutralization and then target those B cells with novel…

Exploring Strategies to Measure and Understand Users’ Preferences in HIV Prevention and Care

Presentation: Advances in short- and long-acting pre-exposure prophylaxis (PrEP) and Antiretroviral Therapy (ART) have fueled the need to understand how individuals make trade-offs and competing decisions regarding their preferred PrEP and ART modalities. In this presentation, Dr. Bauermeister provides an overview of the state-of-the-science regarding how HIV researchers have conceptualized and measured users’ preferences in…

Cirrhosis Management

Presentation: In our upcoming cirrhosis management lecture, we’ll cover the diagnosis and management of cirrhosis, with a focus on HIV patients. We’ll discuss diagnostic methods, including medical history, physical exams, and advanced tests like liver function and imaging studies. For management, we’ll explore lifestyle changes, pharmaceutical options for complications, and the challenges of concurrent HIV…